Mechanism and therapeutic potential of traditional Chinese medicine extracts in sepsis
- PMID: 39021837
- PMCID: PMC11251979
- DOI: 10.3389/fphar.2024.1365639
Mechanism and therapeutic potential of traditional Chinese medicine extracts in sepsis
Abstract
Sepsis is a complex syndrome characterized by multi-organ dysfunction, due to the presence of harmful microorganisms in blood which could cause mortality. Complications associated with sepsis involve multiple organ dysfunction. The pathogenesis of sepsis remains intricate, with limited treatment options and high mortality rates. Traditional Chinese medicine (TCM) has consistently demonstrated to have a potential on various disease management. Its complements include reduction of oxidative stress, inhibiting inflammatory pathways, regulating immune responses, and improving microcirculation. Traditional Chinese medicine can mitigate or even treat sepsis in a human system. This review examines progress on the use of TCM extracts for treating sepsis through different pharmacological action and its mechanisms. The potential targets of TCM extracts and active ingredients for the treatment of sepsis and its complications have been elucidated through molecular biology research, network pharmacology prediction, molecular docking analysis, and visualization analysis. Our aim is to provide a theoretical basis and empirical support for utilizing TCM in the treatment of sepsis and its complications while also serving as a reference for future research and development of sepsis drugs.
Keywords: extracts; mechanism; pharmacological action; sepsis; traditional Chinese medicine.
Copyright © 2024 Fu, Li, Chen, Liang, Zhao, He, Ma, Yang and Wang.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures



Similar articles
-
Traditional Chinese medicine for treatment of sepsis and related multi-organ injury.Front Pharmacol. 2023 Jan 19;14:1003658. doi: 10.3389/fphar.2023.1003658. eCollection 2023. Front Pharmacol. 2023. PMID: 36744251 Free PMC article. Review.
-
Mechanisms of multi-omics and network pharmacology to explain traditional chinese medicine for vascular cognitive impairment: A narrative review.Phytomedicine. 2024 Jan;123:155231. doi: 10.1016/j.phymed.2023.155231. Epub 2023 Nov 19. Phytomedicine. 2024. PMID: 38007992 Review.
-
Research on the signaling pathways related to the intervention of traditional Chinese medicine in Parkinson's disease:A literature review.J Ethnopharmacol. 2024 May 23;326:117850. doi: 10.1016/j.jep.2024.117850. Epub 2024 Feb 6. J Ethnopharmacol. 2024. PMID: 38331124 Review.
-
Decoding the underlying mechanisms of Di-Tan-Decoction in treating intracerebral hemorrhage based on network pharmacology.BMC Complement Med Ther. 2023 Feb 10;23(1):44. doi: 10.1186/s12906-022-03831-7. BMC Complement Med Ther. 2023. PMID: 36765346 Free PMC article.
-
[Role of Mitophagy Affecting Macrophage Polarization in Immunomodulationin Sepsis and Traditional Chinese Medicine Intervention:A Review].Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2024 Oct;46(5):720-731. doi: 10.3881/j.issn.1000-503X.15849. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2024. PMID: 39502054 Review. Chinese.
Cited by
-
Pathogenesis and treatment strategies of sepsis-induced myocardial injury: modern and traditional medical perspectives.Int J Biol Sci. 2025 May 15;21(8):3478-3504. doi: 10.7150/ijbs.111288. eCollection 2025. Int J Biol Sci. 2025. PMID: 40520010 Free PMC article. Review.
-
Systematic review and meta-analysis of Jueyin disease theory in the treatment of gangrene with traditional Chinese medicine formulations.Syst Rev. 2025 Apr 30;14(1):95. doi: 10.1186/s13643-025-02854-8. Syst Rev. 2025. PMID: 40307953 Free PMC article.
-
Efficacy and safety of 11 oral preparations of single-source traditional Chinese medicines in the treatment of unstable angina pectoris: a systematic review and network meta-analysis.Front Pharmacol. 2025 Jun 24;16:1582661. doi: 10.3389/fphar.2025.1582661. eCollection 2025. Front Pharmacol. 2025. PMID: 40630122 Free PMC article.
References
-
- Abu Bakar N. H., Sukari M. A., Rahmani M., Sharif A. M., Khalid K., Yusuf U. K. (2007). Chemical constituents from stem barks and roots of Murraya koenigii (Rutaceae). Malays. J. Anal. Sci. 11, 173–176.
-
- Biemond B. J., Levi M., Ten Cate H., Van Der Poll T., Büller H. R., Hack C. E., et al. (1995). Plasminogen activator and plasminogen activator inhibitor I release during experimental endotoxaemia in chimpanzees: effect of interventions in the cytokine and coagulation cascades. Clin. Sci. 88, 587–594. 10.1042/cs0880587 - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources